UniProt ID | IFT81_HUMAN | |
---|---|---|
UniProt AC | Q8WYA0 | |
Protein Name | Intraflagellar transport protein 81 homolog | |
Gene Name | IFT81 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 676 | |
Subcellular Localization | Cell projection, cilium . | |
Protein Description | Component of the intraflagellar transport (IFT) complex B: together with IFT74, forms a tubulin-binding module that specifically mediates transport of tubulin within the cilium. Binds tubulin via its CH (calponin-homology)-like region. Required for ciliogenesis.. | |
Protein Sequence | MSDQIKFIMDSLNKEPFRKNYNLITFDSLEPMQLLQVLSDVLAEIDPKQLVDIREEMPEQTAKRMLSLLGILKYKPSGNATDMSTFRQGLVIGSKPVIYPVLHWLLQRTNELKKRAYLARFLIKLEVPSEFLQDETVADTNKQYEELMEAFKTLHKEYEQLKISGFSTAEIRKDISAMEEEKDQLIKRVEHLKKRVETAQNHQWMLKIARQLRVEKEREEYLAQQKQEQKNQLFHAVQRLQRVQNQLKSMRQAAADAKPESLMKRLEEEIKFNLYMVTEKFPKELENKKKELHFLQKVVSEPAMGHSDLLELESKINEINTEINQLIEKKMMRNEPIEGKLSLYRQQASIISRKKEAKAEELQEAKEKLASLEREASVKRNQTREFDGTEVLKGDEFKRYVNKLRSKSTVFKKKHQIIAELKAEFGLLQRTEELLKQRHENIQQQLQTMEEKKGISGYSYTQEELERVSALKSEVDEMKGRTLDDMSEMVKKLYSLVSEKKSALASVIKELRQLRQKYQELTQECDEKKSQYDSCAAGLESNRSKLEQEVRRLREECLQEESRYHYTNCMIKNLEVQLRRATDEMKAYISSDQQEKRKAIREQYTKNTAEQENLGKKLREKQKVIRESHGPNMKQAKMWRDLEQLMECKKQCFLKQQSQTSIGQVIQEGGEDRLIL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSDQIKFIM ------CCHHHHHHH | 37.92 | 22814378 | |
2 | Phosphorylation | ------MSDQIKFIM ------CCHHHHHHH | 37.92 | 21406692 | |
14 | Ubiquitination | FIMDSLNKEPFRKNY HHHHHCCCCCCCCCC | 72.55 | - | |
61 (in isoform 3) | Phosphorylation | - | 32.27 | - | |
61 | Phosphorylation | REEMPEQTAKRMLSL HHHCCHHHHHHHHHH | 32.27 | 19664994 | |
73 | Sumoylation | LSLLGILKYKPSGNA HHHHHHHHCCCCCCC | 49.67 | - | |
75 | Ubiquitination | LLGILKYKPSGNATD HHHHHHCCCCCCCCC | 30.99 | - | |
75 | Sumoylation | LLGILKYKPSGNATD HHHHHHCCCCCCCCC | 30.99 | - | |
144 | Phosphorylation | VADTNKQYEELMEAF CCCCHHHHHHHHHHH | 17.00 | 29496907 | |
152 | Ubiquitination | EELMEAFKTLHKEYE HHHHHHHHHHHHHHH | 58.17 | - | |
156 | Ubiquitination | EAFKTLHKEYEQLKI HHHHHHHHHHHHHHC | 66.17 | - | |
158 | Phosphorylation | FKTLHKEYEQLKISG HHHHHHHHHHHHCCC | 17.49 | - | |
182 | Ubiquitination | ISAMEEEKDQLIKRV HHHCHHHHHHHHHHH | 54.80 | - | |
187 | Ubiquitination | EEKDQLIKRVEHLKK HHHHHHHHHHHHHHH | 60.01 | - | |
216 | Ubiquitination | ARQLRVEKEREEYLA HHHHHHHHHHHHHHH | 60.25 | - | |
226 | Ubiquitination | EEYLAQQKQEQKNQL HHHHHHHHHHHHHHH | 43.66 | - | |
230 | Ubiquitination | AQQKQEQKNQLFHAV HHHHHHHHHHHHHHH | 46.00 | - | |
248 | Ubiquitination | QRVQNQLKSMRQAAA HHHHHHHHHHHHHHH | 32.23 | - | |
249 | Phosphorylation | RVQNQLKSMRQAAAD HHHHHHHHHHHHHHH | 27.99 | - | |
261 | Phosphorylation | AADAKPESLMKRLEE HHHCCHHHHHHHHHH | 42.14 | - | |
264 | Ubiquitination | AKPESLMKRLEEEIK CCHHHHHHHHHHHHH | 60.15 | - | |
290 (in isoform 3) | Acetylation | - | 68.09 | - | |
290 | Acetylation | KELENKKKELHFLQK HHHHHHHHHHHHHHH | 68.09 | 19608861 | |
297 | Ubiquitination | KELHFLQKVVSEPAM HHHHHHHHHHCCCCC | 46.91 | - | |
329 | Ubiquitination | EINQLIEKKMMRNEP HHHHHHHHHHHCCCC | 38.69 | - | |
330 | Ubiquitination | INQLIEKKMMRNEPI HHHHHHHHHHCCCCC | 25.74 | - | |
333 | Methylation | LIEKKMMRNEPIEGK HHHHHHHCCCCCCCH | 40.64 | 12019789 | |
340 | Ubiquitination | RNEPIEGKLSLYRQQ CCCCCCCHHHHHHHH | 23.32 | - | |
342 (in isoform 3) | Phosphorylation | - | 27.17 | - | |
342 | Phosphorylation | EPIEGKLSLYRQQAS CCCCCHHHHHHHHHH | 27.17 | 18767875 | |
345 | Methylation | EGKLSLYRQQASIIS CCHHHHHHHHHHHHH | 27.68 | 12019799 | |
349 | Phosphorylation | SLYRQQASIISRKKE HHHHHHHHHHHHHHH | 19.00 | 24719451 | |
352 | Phosphorylation | RQQASIISRKKEAKA HHHHHHHHHHHHHHH | 36.06 | 24719451 | |
371 | Phosphorylation | EAKEKLASLEREASV HHHHHHHHHHHHHHH | 41.00 | 25849741 | |
377 | Phosphorylation | ASLEREASVKRNQTR HHHHHHHHHCCCCCC | 24.34 | 29514088 | |
383 | Phosphorylation | ASVKRNQTREFDGTE HHHCCCCCCCCCCCE | 35.40 | - | |
393 | Ubiquitination | FDGTEVLKGDEFKRY CCCCEEECHHHHHHH | 70.28 | - | |
398 | Ubiquitination | VLKGDEFKRYVNKLR EECHHHHHHHHHHHH | 40.55 | - | |
400 | Phosphorylation | KGDEFKRYVNKLRSK CHHHHHHHHHHHHCC | 14.68 | - | |
414 | Ubiquitination | KSTVFKKKHQIIAEL CCHHHHHHHHHHHHH | 41.13 | - | |
436 | Ubiquitination | QRTEELLKQRHENIQ HHHHHHHHHHHHHHH | 58.89 | - | |
453 | Ubiquitination | LQTMEEKKGISGYSY HHHHHHHCCCCCCCC | 65.83 | - | |
472 | Ubiquitination | LERVSALKSEVDEMK HHHHHHHHHHHHHHC | 44.26 | - | |
479 | 2-Hydroxyisobutyrylation | KSEVDEMKGRTLDDM HHHHHHHCCCCHHHH | 43.10 | - | |
479 | Ubiquitination | KSEVDEMKGRTLDDM HHHHHHHCCCCHHHH | 43.10 | - | |
492 | Ubiquitination | DMSEMVKKLYSLVSE HHHHHHHHHHHHHHH | 41.04 | - | |
500 | 2-Hydroxyisobutyrylation | LYSLVSEKKSALASV HHHHHHHHHHHHHHH | 44.51 | - | |
500 | Ubiquitination | LYSLVSEKKSALASV HHHHHHHHHHHHHHH | 44.51 | - | |
501 | Ubiquitination | YSLVSEKKSALASVI HHHHHHHHHHHHHHH | 36.59 | - | |
509 | Ubiquitination | SALASVIKELRQLRQ HHHHHHHHHHHHHHH | 48.84 | - | |
529 | Ubiquitination | TQECDEKKSQYDSCA HHHHHHHHHHHHHHH | 40.52 | - | |
532 | Phosphorylation | CDEKKSQYDSCAAGL HHHHHHHHHHHHHHH | 19.54 | 29759185 | |
544 | Phosphorylation | AGLESNRSKLEQEVR HHHHHHHHHHHHHHH | 45.93 | 29457462 | |
545 | Ubiquitination | GLESNRSKLEQEVRR HHHHHHHHHHHHHHH | 53.45 | - | |
586 | Ubiquitination | RRATDEMKAYISSDQ HHCCHHHHHHHCCCH | 35.67 | - | |
588 | Phosphorylation | ATDEMKAYISSDQQE CCHHHHHHHCCCHHH | 8.87 | - | |
596 | Ubiquitination | ISSDQQEKRKAIREQ HCCCHHHHHHHHHHH | 55.66 | - | |
596 | Acetylation | ISSDQQEKRKAIREQ HCCCHHHHHHHHHHH | 55.66 | 19810283 | |
596 | 2-Hydroxyisobutyrylation | ISSDQQEKRKAIREQ HCCCHHHHHHHHHHH | 55.66 | - | |
598 | Ubiquitination | SDQQEKRKAIREQYT CCHHHHHHHHHHHHH | 60.27 | - | |
604 | Phosphorylation | RKAIREQYTKNTAEQ HHHHHHHHHHHHHHH | 18.22 | 27067055 | |
605 | Phosphorylation | KAIREQYTKNTAEQE HHHHHHHHHHHHHHH | 19.94 | 27067055 | |
606 | Ubiquitination | AIREQYTKNTAEQEN HHHHHHHHHHHHHHH | 47.57 | - | |
628 | Phosphorylation | KQKVIRESHGPNMKQ HHHHHHHHHCCCHHH | 24.72 | 24670416 | |
649 | Ubiquitination | LEQLMECKKQCFLKQ HHHHHHHHHHHHHHC | 32.35 | - | |
650 | Ubiquitination | EQLMECKKQCFLKQQ HHHHHHHHHHHHHCC | 65.05 | - | |
658 | Phosphorylation | QCFLKQQSQTSIGQV HHHHHCCCCCCHHHH | 32.69 | 29978859 | |
660 | Phosphorylation | FLKQQSQTSIGQVIQ HHHCCCCCCHHHHHH | 27.79 | 21815630 | |
661 | Phosphorylation | LKQQSQTSIGQVIQE HHCCCCCCHHHHHHC | 19.65 | 29978859 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of IFT81_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IFT81_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IFT81_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-290, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-61, AND MASSSPECTROMETRY. |